[Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C].
作者信息
Lambot Frédéric, Hanson Bernard, Sztern Bernard
机构信息
Hôpital Molière-Longchamps, HIS, médecine interne, Bruxelles, 1190 Bruxelles, Belgique.
出版信息
Presse Med. 2010 Nov;39(11):1207-10. doi: 10.1016/j.lpm.2010.04.016. Epub 2010 Jul 6.
PMID:20609558
Abstract
摘要
相似文献
1
[Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C].[一名慢性丙型肝炎患者在接受聚乙二醇化干扰素α-2a和利巴韦林治疗后出现由ADAMTS13抑制剂介导的血栓性血小板减少性紫癜]
Presse Med. 2010 Nov;39(11):1207-10. doi: 10.1016/j.lpm.2010.04.016. Epub 2010 Jul 6.
2
Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b.在接受聚乙二醇化干扰素-α/2b治疗的慢性丙型肝炎患者中发生血栓性血小板减少性紫癜并导致致命后果。
Scand J Gastroenterol. 2007 Mar;42(3):408-9. doi: 10.1080/00365520600930685.
3
4
[Thrombotic thrombocytopenic purpura associated with interferon therapy in a HIV and HCV co-infected woman].
Rev Med Interne. 2013 Dec;34(12):773-5. doi: 10.1016/j.revmed.2013.03.003. Epub 2013 May 9.
5
Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.聚乙二醇化干扰素-α治疗复发性自身免疫性血栓性血小板减少性紫癜患者的慢性丙型肝炎
Transfus Med. 2013 Feb;23(1):66-68. doi: 10.1111/j.1365-3148.2012.01197.x. Epub 2012 Oct 29.
6
Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis.血栓性血小板减少性紫癜并发于慢性丙型肝炎的干扰素治疗。
Gastroenterol Clin Biol. 2008 Feb;32(2):145-6. doi: 10.1016/j.gcb.2007.12.019.
7
[Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].[聚乙二醇干扰素和利巴韦林治疗丙型肝炎患者时的急性门静脉血栓形成]
Gastroenterol Hepatol. 2008 Jan;31(1):18-21. doi: 10.1157/13114566.
8
Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.聚乙二醇化干扰素-α-2a、利巴韦林和维生素D联合治疗慢性丙型肝炎患者后出现白癜风。
J Dermatol. 2013 Sep;40(9):772-3. doi: 10.1111/1346-8138.12234. Epub 2013 Jul 16.
9
Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.接受聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者的医源性色素沉着。
J Am Acad Dermatol. 2009 May;60(5):882-3. doi: 10.1016/j.jaad.2008.10.006.
10
Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C.聚乙二醇化干扰素α-2a联合利巴韦林治疗丙型肝炎合并肾病综合征1例
Indian J Gastroenterol. 2010 Jun;29(3):124-5.
引用本文的文献
1
Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.利妥昔单抗成功治疗干扰素治疗丙型肝炎患者并发的血栓性血小板减少性紫癜
Hematol Rep. 2013 Jan 25;5(1):5-7. doi: 10.4081/hr.2013.e2.
2
Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.ADAMTS13的测定及其补充ADAMTS13治疗对改善失代偿期肝硬化患者生存率的临床意义
Int J Hepatol. 2011;2011:759047. doi: 10.4061/2011/759047. Epub 2011 Jul 18.
Zotero 插件